Skip to main content
. 2016 Jun 21;11(6):e0157335. doi: 10.1371/journal.pone.0157335

Fig 3. Vaccinia-specific PRNT GMTs by Week (IAS, N = 119).

Fig 3

Administrations at week 0 (Group MM: first MVA vaccination; Group PM: Placebo) and at week 4 (Group MM: second MVA vaccination; Group PM: first MVA vaccination). No samples were taken between week 8 and 32, therefore the graph was cut. IAS = Immunogenicity Analysis Set, GMT = geometric mean titer, PRNT = plaque reduction neutralization test, CI = confidence interval.